Анна Валерьевна Винокурова

Анна Валерьевна Винокурова

Auto-generated profile, based on publicly available information

Анна Валерьевна Винокурова

National Medical Research Center for Children’s Health

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2021 in Experimental and Clinical Gastroenterology
Verified
Journal Article
Open access
PDF file
ISI. Sokolov
I. Sokolov
OSO. I. Simonova
O. I. Simonova
ERE. A. Roslavtseva
E. A. Roslavtseva
VCV. P. Chernevich
V. P. Chernevich
AVA. V. Vinokurova
A. V. Vinokurova
SPS. D. Polyakov
S. D. Polyakov
The pulmonary function which determines the prognosis of the disease in patients with cystic fibrosis (CF) depends directly on their nutritional status. Normal body mass index (BMI) for a given age/sex of the patient is considered to correspond with normal nutritional status. However, it is known that in CF patients only lean body mass (musculoskeletal and visceral) correlates directly with lung function. Bioimpedansometry, as the he method for assessing body composition in children with cystic fibrosis is actual, informative and available in pediatric practice. Body composition indicators can be used in these patients not only for diagnostic and prognostic purposes, but also for monitoring the course of the disease in a particular patient and correction of nutrition.The estimation of body composition with bioimpedance method in children with CF, carried out in this study, shows that in children with normal and even low BMI, the percentage of lean body mass is low, which requires measures to increase muscle/bone mass, the strength of the respiratory muscles especially, both by correcting the protein component of the diet, and by increasing physical / sports activity, in addition to compulsory respiratory physiotherapy.

27 June 2023 in Russian Pediatric Journal
Verified
Journal Article
Open access
PDF file
MPMarina O. Prokhorenkova
Marina O. Prokhorenkova
АПАлександр Сергеевич Потапов
Александр Сергеевич Потапов
ГКГригорий Алексеевич Королёв
Григорий Алексеевич Королёв
АВАнна Валерьевна Винокурова
Анна Валерьевна Винокурова
КНКристина Максимовна Носенко
Кристина Максимовна Носенко
АФАндрей Петрович Фисенко
Андрей Петрович Фисенко
Introduction. The use of non-invasive methods for examining patients with endoscopic remission can be useful in identifying the need for endoscopic interventions and assessing disease activity over time. Materials and methods. We analyzed two hundred thirty two medical histories of children with Crohn’s disease (CD) who were examined and treated at the National Medical Research Center for Children’s Health. The relationship between the CD simple endoscopic score (SES-CD) and the newly developed mucosal inflammation noninvasive index (MINI) was determined. Similarly, data from 80 children with ulcerative colitis were examined to identify correlations between the ulcerative colitis endoscopic index of severity (UCEIS) and MINI. Results. Among all forms of Crohn’s disease, a direct strong correlation was found between MINI and SES-CD (R = 0.81, p < 0.001). A MINI value > 5 indicated the absence of mucosal healing (SES-CD > 2 points) with a sensitivity of 73% and a specificity of 84%, and a MINI value ≥13 predicted high activity of Crohn’s disease (SES-CD ≥ 16 points) with sensitivity and specificity of 79% and 88%, respectively. The correlation between MINI and UCEIS in patients with ulcerative colitis revealed an average relationship, which requires further modification of the index in accordance with the characteristics of the course of the disease. Conclusion. The newly developed MINI is a simple and intuitive tool for assessing mucosal inflammation in CD children.

16 September 2024 in Russian Pediatric Journal
Verified
Journal Article
Open access
PDF file
OUOlga V. Usoltseva
Olga V. Usoltseva
АПАлександр Сергеевич Потапов
Александр Сергеевич Потапов
АААнтон Олегович Анушенко
Антон Олегович Анушенко
АВАнна Валерьевна Винокурова
Анна Валерьевна Винокурова
АКАнастасия Евгеньевна Красновидова
Анастасия Евгеньевна Красновидова
GMGoar B. Movsisyan
Goar B. Movsisyan
Ulcerative colitis is a chronic relapsing inflammatory disease of the colon with continuous spread of lesions from the rectum in the proximal direction. The etiology of the disease is unknown, but it is assumed to be developed as a result of a combination of several factors. The clinical picture is often similar to the picture of intestinal infection, which complicates the timely diagnosis of the disease, especially in children. Refractory to standard therapy limits therapeutic options and increases the frequency of surgical interventions. However, the emergence of new drugs, such as upadacitinib, opens up new opportunities for treating such patients and studying the effectiveness of therapy. We present a case of successful treatment of ulcerative colitis with upadacitinib in a child with the onset of the disease at the age of 6 months. The purpose of the description is to show the possibilities of using the janus kinase blocker Upadacitinib in severe ulcerative colitis in a child with a very early onset of the disease and without effect from previous therapy. The importance of early diagnosis and therapy is emphasized.

27 December 2023 in Russian Pediatric Journal
Verified
Journal Article
Open access
PDF file
MPMarina O. Prokhorenkova
Marina O. Prokhorenkova
КНКристина Максимовна Носенко
Кристина Максимовна Носенко
МОМария Алексеевна Орлова
Мария Алексеевна Орлова
АВАнна Валерьевна Винокурова
Анна Валерьевна Винокурова
ВКВлада Александровна Казакова
Влада Александровна Казакова
АПАлександр Сергеевич Потапов
Александр Сергеевич Потапов
Introduction. The incidence and prevalence of inflammatory bowel disease (IBD) in children is increasing steadily. The diagnosis is often delayed that can lead to an increased risk of complications and significantly decrease the quality of life in the child. The identification of reasons associated with prolonged diagnostics must bring down healthcare costs, reduce the frequency of surgical interventions and use of biological agents. The aim of our study was to determine the duration of diagnosis and associated factors in IBD children. Materials and methods. The research held at the National Medical Research Center for Children’s Health included the analysis of three hundred sixty four medical records of children diagnosed with ulcerative colitis (UC) or Crohn’s Disease (CD). This investigation assessed the time of onset of the first symptoms, the first visit to a doctor, the time of establishing the diagnosis, and the first symptoms. The diagnostic time and delay for all IBD were determined. Results. The study included 286 patients, including 157 CD and 129 UC. The diagnostic delay was 18 months for CD, and 6 months for UC. The manifestation of the disease with extraintestinal symptoms in CD was found to increase the chance of a diagnosis duration of more than 18 months by 8.88 times (95% CI 3.4–23.06, p < 0.001), and in UC — more than 6 months by 4.98 times (95% CI 1.52–16.3, p = 0.009). Moreover, the absence of liquid stools, blood in the stool, low-grade fever, and abdominal pain in CD can lead to an increase in diagnostic time. It was also found that UC boys are diagnosed much longer. Conclusion. CD requires more time to make a diagnosis than UC, which is due to the peculiarity of the clinical course of the di­sease. Despite the fact that a doctor has consulted patients in time, a delay in establishing a diagnosis occurred at the examination stage, so that requires additional alertness from the specialist’s side.

27 February 2024 in Pediatrics. Consilium Medicum
Verified
Journal Article
Open access
PDF file
AVAnna V. Vinokurova
Anna V. Vinokurova
MLMaksim M. Lokhmatov
Maksim M. Lokhmatov
APAlexander S. Potapov
Alexander S. Potapov
TBTatyana N. Budkina
Tatyana N. Budkina
MPMarina O. Prokhorenkova
Marina O. Prokhorenkova
AFAndrei P. Fisenko
Andrei P. Fisenko
Background. Endoscopic diagnostic methods, namely ileocolonoscopy with biopsy, are the „gold standard“ in the diagnosis of ulcerative colitis. Due to the improvement of methods for the diagnosis of ulcerative colitis, the use of endoscopic ultrasonography, that combines endoscopic and ultrasound diagnostic methods, has attracted widespread attention. Endoscopic ultrasonography allows examination of the mucous membrane and the underlying layers of the intestinal wall, which makes it possible to measure the thickness of the intestinal wall. Both in Russia and abroad, there are no publications on the use of endoscopic ultrasonography for ulcerative colitis in children, and that requires further research in this area. Aim. To evaluate the possibilities of endoscopic ultrasonography in order to determine the activity of ulcerative colitis in children. Materials and methods. The study includes 97 children with an established diagnosis of ulcerative colitis. All children underwent ileocolonoscopy and endoscopic ultrasonography. The UCEIS scale (Ulcerative Colitis Endoscopic Index of Severity) was used to assess endoscopic activity. During endoscopic ultrasonography, the thickness of the intestinal wall and blood flow were evaluated using the color Doppler mapping mode. Results. According to the study, there was a statistically significant increase in the thickness of the intestinal wall amid the development of endoscopic activity. The statistically significant increase in the activity of blood flow in the intestinal wall was found. Conclusion. Endoscopic ultrasonography is a relatively new research method with a number of functions that can be used to solve complex diagnostic problems in children with ulcerative colitis. The ability to measure the thickness of the intestinal wall and assess the severity of blood flow allows endoscopic ultrasonography to assess patients with ulcerative colitis dynamically, which makes it a promising method in primary diagnosis.

27 June 2025 in Russian Pediatric Journal
Verified
Journal Article
Open access
PDF file
АКАнастасия Евгеньевна Красновидова
Анастасия Евгеньевна Красновидова
VOVladislav I. Oldakovsky
Vladislav I. Oldakovsky
АДАнастасия Сергеевна Дроздова
Анастасия Сергеевна Дроздова
АВАнна Валерьевна Винокурова
Анна Валерьевна Винокурова
КЗКарина Игоревна Зенкова
Карина Игоревна Зенкова
АПАлександр Сергеевич Потапов
Александр Сергеевич Потапов
Introduction. Inflammatory activity in ulcerative colitis (UC) and Crohn’s disease (CD) is assessed comprehensively using endoscopic, clinical, and laboratory parameters. Mucosal friability (MF), verified during colonoscopy, is an indicator of mucosal healing — the therapeutic goal in inflammatory bowel disease (IBD) and a significant prognostic factor for UC clinical outcomes. Aim: To evaluate the role of MF in determining IBD activity in children. Materials and methods. A clinical, prospective, observational cohort study included 81 IBD child, of whom 42 patients comprised the UC group and 39 the CD group. Disease activity was evaluated using pediatric clinical activity indices for UC and CD, as well as the endoscopic activity index for UC and the simple endoscopic score for CD. MF was assessed with a scale where 0 points corresponded to the absence of pathological changes, 1 point to intramucosal hemorrhages, and 2 points to contact bleeding. Results. In UC patients there were close positive correlations between the endoscopic activity of the disease and the severity of CD (p < 0.001; r = 0.713) and a moderate closeness between clinical activity and CD (p < 0.001; r = 0.503). In CD children, positive correlations of moderate crowding were found between the endoscopic activity of the disease and the severity of CD (p = 0.003; r = 0.464). However, in CD patients, the correlations between the clinical activity of the disease and CD are not significant (p = 0.184; r = 0.223). Conclusion. The determination of the contact difference to determine the healing of the mucous membrane in IBD is an informative method and has diagnostic significance in UC patients, in which the inflammatory process is located superficially in the mucous layer. The clinical interpretation of contact vulnerability requires mandatory comparison with clinical and anamnestic data and laboratory test results.